| Myeloid-derived suppressor cells: linking inflammation and cancer S Ostrand-Rosenberg, P Sinha The Journal of Immunology 182 (8), 4499-4506, 2009 | 2263 | 2009 |
| Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine MK Srivastava, P Sinha, VK Clements, P Rodriguez, ... Cancer research 70 (1), 68-77, 2010 | 1111 | 2010 |
| Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response P Sinha, VK Clements, SK Bunt, SM Albelda, S Ostrand-Rosenberg The Journal of Immunology 179 (2), 977-983, 2007 | 1073 | 2007 |
| Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells P Sinha, VK Clements, AM Fulton, S Ostrand-Rosenberg Cancer research 67 (9), 4507-4513, 2007 | 910 | 2007 |
| Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells P Sinha, C Okoro, D Foell, HH Freeze, S Ostrand-Rosenberg, ... The Journal of Immunology 181 (7), 4666-4675, 2008 | 859 | 2008 |
| Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression SK Bunt, L Yang, P Sinha, VK Clements, J Leips, S Ostrand-Rosenberg Cancer research 67 (20), 10019-10026, 2007 | 787 | 2007 |
| Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression SK Bunt, P Sinha, VK Clements, J Leips, S Ostrand-Rosenberg The Journal of Immunology 176 (1), 284-290, 2006 | 666 | 2006 |
| Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression S Ostrand-Rosenberg, P Sinha, DW Beury, VK Clements Seminars in cancer biology 22 (4), 275-281, 2012 | 625 | 2012 |
| Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease P Sinha, VK Clements, S Ostrand-Rosenberg The Journal of Immunology 174 (2), 636-645, 2005 | 552 | 2005 |
| Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells EM Hanson, VK Clements, P Sinha, D Ilkovitch, S Ostrand-Rosenberg The Journal of Immunology 183 (2), 937-944, 2009 | 544 | 2009 |
| Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease EA Danna, P Sinha, M Gilbert, VK Clements, BA Pulaski, ... Cancer research 64 (6), 2205-2211, 2004 | 427 | 2004 |
| RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis O Turovskaya, D Foell, P Sinha, T Vogl, R Newlin, J Nayak, M Nguyen, ... Carcinogenesis 29 (10), 2035-2043, 2008 | 381 | 2008 |
| Interleukin-13–regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis P Sinha, VK Clements, S Ostrand-Rosenberg Cancer research 65 (24), 11743-11751, 2005 | 348 | 2005 |
| A nonclassical non-Vα14Jα18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance M Terabe, J Swann, E Ambrosino, P Sinha, S Takaku, Y Hayakawa, ... The Journal of experimental medicine 202 (12), 1627-1633, 2005 | 344 | 2005 |
| Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4 SK Bunt, VK Clements, EM Hanson, P Sinha, S Ostrand-Rosenberg Journal of Leucocyte Biology 85 (6), 996-1004, 2009 | 313 | 2009 |
| Systematics of moder Foraminifera BK Sen Gupta, BK Sen Gupta Modern foraminifera, 7-36, 2003 | 270 | 2003 |
| HMGB1 enhances immune suppression by facilitating the differentiation and suppressive activity of myeloid-derived suppressor cells KH Parker, P Sinha, LA Horn, VK Clements, H Yang, J Li, KJ Tracey, ... Cancer research 74 (20), 5723-5733, 2014 | 245 | 2014 |
| Cross-talk among myeloid-derived suppressor cells, macrophages, and tumor cells impacts the inflammatory milieu of solid tumors DW Beury, KH Parker, M Nyandjo, P Sinha, KA Carter, ... Journal of leukocyte biology 96 (6), 1109-1118, 2014 | 209 | 2014 |
| Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell–expressed FasL P Sinha, O Chornoguz, VK Clements, KA Artemenko, RA Zubarev, ... Blood, The Journal of the American Society of Hematology 117 (20), 5381-5390, 2011 | 176 | 2011 |
| Tumor immunity: a balancing act between T cell activation, macrophage activation and tumor-induced immune suppression P Sinha, VK Clements, S Miller, S Ostrand-Rosenberg Cancer Immunology, Immunotherapy 54, 1137-1142, 2005 | 171 | 2005 |